The company says that it has been issued with pant number 7,211,274 from the US Patent Office for its Hair Growth Formulationm, which features its Tocomin Suprabrio delivery system.
The formulation is said to be a natural full spectrum palm tocotrienol complex derived from vitamin E, which has shown good results in the treatment of men and women suffering from andogrenetic alopecia, or pattern baldness.
Tocotrienols come in both natural and synthetic forms and are also said to reduce the effect of free radicals, with studies pinpointing that this property gives the compound an anti-cancer effect.
Tocotrienols studies show effectiveness against baldness Studies carried out on tocotrienols have already indicated that there is evidence that it can be incorporated into treatments to help prevent hair loss, and indeed there are already several supplement products on the market that make this type of claim.
Pattern baldness condition is said to affect about 50 percent of men and women over the age of 40, and is said to be caused by three independent factors, testosterone levels, genetic disposition and advancing age.
The Carotech treatment concentrates on providing a novel, bio-enhanced composition that claims to increae the number of hairs and prevent hair loss.
The treatment is said to enhance the bio-availibilty of toctotrienols by around 250 percent, helping to boost the bodies natural levels of the compound.
Product launch boosts portfolio "This patent is a significant development within Carotech as it adds important depth to Carotech's intellectual property portfolio," said WH Leong, company president.
"It reaffirms our commitment as the leading supplier of tocotrienol, to investing in intellectual property with a long term vision for the market," he added.
The company says the formulation will have applications for personal care products and the dietary supplements market.